Literature DB >> 12546700

PI3K-signalling in B- and T-cells: insights from gene-targeted mice.

K Okkenhaug1, B Vanhaesebroeck.   

Abstract

Phosphoinositide 3-kinases (PI3Ks) are important signalling enzymes in most cell types. Recent gene targeting studies have shed light on the importance of this family of lipid kinases in the immune system, and the complex mechanisms by which these kinases are regulated in vivo. We have recently reported a phenotype of mice in which the p110 delta PI3K catalytic subunit was inactivated by point mutation. In the present paper, we compare and contrast the phenotypes of p110 delta mutant mice with those of mice that lack p85 alpha or p110 gamma, and discuss these in the context of PI3K signalling in B- and T-cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12546700     DOI: 10.1042/bst0310270

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  20 in total

1.  Distinct roles of adenylyl cyclase VII in regulating the immune responses in mice.

Authors:  Biyan Duan; Richard Davis; Eva L Sadat; Julie Collins; Paul C Sternweis; Dorothy Yuan; Lily I Jiang
Journal:  J Immunol       Date:  2010-05-26       Impact factor: 5.422

Review 2.  Negative regulators in homeostasis of naïve peripheral T cells.

Authors:  Jaime F Modiano; Lisa D S Johnson; Donald Bellgrau
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

3.  Targeting PI3K in Cancer: Any Good News?

Authors:  Miriam Martini; Elisa Ciraolo; Federico Gulluni; Emilio Hirsch
Journal:  Front Oncol       Date:  2013-05-08       Impact factor: 6.244

Review 4.  The Emerging Role of PI3K Inhibitors in the Treatment of Hematological Malignancies: Preclinical Data and Clinical Progress to Date.

Authors:  Till Seiler; Grit Hutter; Martin Dreyling
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

5.  PI3K Inhibition Reduces Mammary Tumor Growth and Facilitates Antitumor Immunity and Anti-PD1 Responses.

Authors:  Jiqing Sai; Philip Owens; Sergey V Novitskiy; Oriana E Hawkins; Anna E Vilgelm; Jinming Yang; Tammy Sobolik; Nicole Lavender; Andrew C Johnson; Colt McClain; Gregory D Ayers; Mark C Kelley; Melinda Sanders; Ingrid A Mayer; Harold L Moses; Mark Boothby; Ann Richmond
Journal:  Clin Cancer Res       Date:  2016-12-21       Impact factor: 12.531

6.  Generation and characterization of p38beta (MAPK11) gene-targeted mice.

Authors:  Victoria A Beardmore; Heather J Hinton; Christina Eftychi; Maria Apostolaki; Maria Armaka; Joanne Darragh; Joanne McIlrath; Julia M Carr; Laura J Armit; Carol Clacher; Loraine Malone; George Kollias; J Simon C Arthur
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

7.  Phosphoinositide 3-kinases gamma and delta, linkers of coordinate C5a receptor-Fcgamma receptor activation and immune complex-induced inflammation.

Authors:  Stephanie Konrad; Syed R Ali; Kristina Wiege; Shahzad N Syed; Linda Engling; Roland P Piekorz; Emilio Hirsch; Bernd Nürnberg; Reinhold E Schmidt; J Engelbert Gessner
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

Review 8.  PIP3 pathway in regulatory T cells and autoimmunity.

Authors:  Masaki Kashiwada; Ping Lu; Paul B Rothman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

9.  Enhanced NK-cell development and function in BCAP-deficient mice.

Authors:  Alexander W MacFarlane; Tetsuo Yamazaki; Min Fang; Luis J Sigal; Tomohiro Kurosaki; Kerry S Campbell
Journal:  Blood       Date:  2008-03-12       Impact factor: 22.113

10.  Phosphoinositide-dependent kinase 1 controls migration and malignant transformation but not cell growth and proliferation in PTEN-null lymphocytes.

Authors:  David K Finlay; Linda V Sinclair; Carmen Feijoo; Caryll M Waugh; Thijs J Hagenbeek; Hergen Spits; Doreen A Cantrell
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.